嵌合蛋白疫苗在小鼠模型中诱导抗蛔虫保护
研究基于既往蛔虫疫苗候选蛋白预测B细胞表位,构建嵌合蛋白并与MPLA佐剂免疫雌性BALB/c小鼠,攻毒后肺幼虫负荷较对照组降低73.54%,IgG应答升高且肺部炎症减轻,提示含多个B细胞表位的嵌合蛋白可增强抗蠕虫保护。
要点
- 嵌合蛋白联合MPLA免疫小鼠攻毒后肺幼虫负荷降低73.54%。
- 嵌合蛋白联合MPLA组IgG应答更高且肺部炎症减轻。
- 含多个B细胞表位的嵌合蛋白为蛔虫疫苗开发提供新思路。
核心结论
- 含多个B细胞表位的嵌合蛋白联合MPLA可在小鼠模型中诱导抗蛔虫感染保护。
研究设计与样本
- 基于既往蛔虫疫苗候选蛋白进行B细胞表位预测并构建嵌合蛋白。
- 雌性BALB/c小鼠每10天皮下免疫共3剂,疫苗为嵌合蛋白联合MPLA。
- 对照组包括单用蛋白、单用MPLA或PBS,免疫后行攻毒感染。
主要发现
- 嵌合蛋白联合MPLA组攻毒后肺幼虫负荷较对照组降低73.54%。
- 嵌合蛋白联合MPLA组IgG应答更高且肺部炎症减轻。
临床怎么用
- 提示嵌合蛋白联合MPLA策略可作为蛔虫疫苗研发的候选方向。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
An estimated 400 million people are infected by parasites of the genus Ascaris and the existing control measures are inefficient. Vaccine development using B cell antigens is a promising strategy for increased protection against this parasite. The present study aimed at developing a chimeric protein capable of conferring protection against infection by Ascaris sp. For this purpose, we performed B-cell epitope predictions on previously described vaccine candidate proteins from Ascaris suum and the corresponding peptides were used to construct a chimeric protein. Female BALB / c mice were immunized subcutaneously in three doses at 10 day intervals with a vaccine formulation comprised of the chimeric protein together with monophosphoryl lipid A (MPLA). Control groups included protein alone, MPLA, or PBS. After challenge infection, animals vaccinated with chimeric protein plus MPLA showed a reduction of 73.54% of larval load in the lung compared to control group animals. Animals immunized with chimeric protein plus MPLA also display higher IgG response and a reduction in lung inflammation. Our study highlights how chimeric proteins containing more than one B cell epitope can enhance immune protection against helminthic infection and offer new approaches to the development of Ascaris vaccines.
引用
- de Castro JC, de Almeida LV, Cardoso MS, et al. Vaccination with chimeric protein induces protection in murine model against ascariasis. Vaccine. 2020. PMID: 33248854. doi:10.1016/j.vaccine.2020.11.046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。